Details of the Drug | DrugMAP

General Information of Drug (ID: DMZ6PRF)

Drug Name

HB-adipose-derived mesenchymal stem cells

Synonyms

HB-adMSCs

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

TTD ID: D01IKM

References

1	ClinicalTrials.gov (NCT04349631) A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19. U.S. National Institutes of Health.